Abstract
Objective
To quantify and compare levels of potential biomarkers in neonates with (i) Bronchopulmonary dysplasia (BPD); (ii) BPD-associated pulmonary hypertension (BPD-PH); (iii) PH without BPD; and (iv) neonates without lung disease at ~36 weeks postmenstrual age.
Study design
Multiple potential biomarkers were measured in plasma samples of 90 patients using a multi-spot enzyme-linked immunosorbent assay. Statistical tests done included one-way ANOVA to compare levels of biomarkers between different groups.
Results
Higher levels of ICAM-1 were present in infants with BPD and correlated with its severity. Infants with BPD have significantly higher levels of ANG-2 and lower levels of ANG-1. Infants with PH have higher levels of: IL-6, IL-8, IL-10, and TNF-α. Infants with BPD-PH have significantly lower levels of MCP-1 and higher levels of IL-1β than infants with PH without BPD.
Conclusion
ICAM-1 may be used as a specific biomarker for diagnosis of BPD and its severity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bhandari A, Bhandari V. Biomarkers in bronchopulmonary dysplasia. Paediatr Respir Rev. 2013;14:173–9.
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.
Lal CV, Ambalavanan N. Biomarkers, early diagnosis, and clinical predictors of BPD. Clin Perinatol. 2015;42:739–54.
Piersigilli F, Lam TT, Vernocchi P, Quagliariello A, Putignani L, Aghai ZH, et al. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics. Metabolomics. 2019;15:20.
Piersigilli F, Bhandari V. Biomarkers in neonatology: the new “omics” of bronchopulmonary dysplasia. J Matern Fetal Neonatal Med. 2016;29:1758–64.
Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed. 2008;93:F455–61.
O’Connor MG, Suthar D, Vera K, Slaughter JC, Maitre NL, Steele S, et al. Pulmonary hypertension in the premature infant population: analysis of echocardiographic findings and biomarkers. Pediatric Pulmonol. 2018;53:302–9.
Littler DR, Harrop SJ, Goodchild SC, Phang JM, Mynott AV, Jiang L, et al. The enigma of the CLIC proteins: ion channels, redox proteins, enzymes, scaffolding proteins? FEBS Lett. 2010;584:2093–101.
Singh H. Two decades with dimorphic Chloride Intracellular Channels (CLICs). FEBS Lett. 2010;584:2112–21.
Wojciak-Stothard B, Abdul-Salam VB, Lao KH, Tsang H, Irwin DC, Lisk C, et al. Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension. Circulation. 2014;129:1770–80.
Gururaja Rao S, Ponnalagu D, Patel NJ, Singh H. Three decades of chloride intracellular channel proteins: from organelle to organ physiology. Curr Protoc Pharmacol. 2018;80:11.21.11–17.
Ren G, Roberts AI, Shi Y. Adhesion molecules: key players in mesenchymal stem cell-mediated immunosuppression. Cell Adhes Migr. 2011;5:20–2.
Glaser K, Speer CP. Pre and postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. In: Bhandari V editor. Bronchopulmonary Dysplasia. Cham: Springer International Publishing; 2016, pp. 55–77.
Ramsay PL, O’Brian Smith E, Hegemier S, Welty SE. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1. Pediatrics. 1998;102:927–32.
Welty SE, Rivera JL, Elliston JF, Smith CV, Zeb T, Ballantyne CM, et al. Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol. 1993;9:393–400.
Ambalavanan N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics. 2009;123:1132–41.
Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med. 2003;47:149–61.
Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Therap. 2005;314:738.
Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12:1286–93.
Thomas W, Seidenspinner S, Kramer BW, Wirbelauer J, Kawczyńska-Leda N, Szymankiewicz M, et al. Airway angiopoietin-2 in ventilated very preterm infants: Association with prenatal factors and neonatal outcome. Pediatr Pulmonol. 2011;46:777–84.
Mohamed WA, Niyazy WH, Mahfouz AA. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Tropical Pediatrics. 2011;57:385–8.
Baier RJ, Loggins J, Kruger TE. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Investig Med. 2001;49:362–9.
Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37:137–48.
Jackson W, Laughon MM. Biomarkers of bronchopulmonary dysplasia. In: Bhandari V editor. Bronchopulmonary dysplasia. Cham: Springer International Publishing; 2016, pp. 129–48.
Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res. 1996;40:250.
Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Investig. 2001;107:1529–36.
Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009;104:236–44.
Groth A, Vrugt B, Brock M, Speich R, Ulrich S, Huber LC. Inflammatory cytokines in pulmonary hypertension. Respir Res. 2014;15:47.
Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis. 2005;8:63–71.
Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.
Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res. 1996;39:966–75.
Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122:920–7.
Funding
This work was supported by a grant from the American Heart Association Grant-in-Aid 16GRNT29430000, and National Institute of Health R01-HL133050, to HS.
Author information
Authors and Affiliations
Contributions
MS designed the study, performed the experiments, carried out the statistical analysis and drafted the initial manuscript. BY did the data collection for the study. PD and DS performed the experiments, assisted with data analysis and reviewed and revised the manuscript. DP and HS performed the experiments, reviewed and revised the manuscript. LN helped design the study, coordinated sample collection, reviewed and revised the manuscript. VB conceptualized and designed the study, supervised the experiments and statistical analysis, reviewed and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Sahni, M., Yeboah, B., Das, P. et al. Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension. J Perinatol 40, 1634–1643 (2020). https://doi.org/10.1038/s41372-020-00788-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-020-00788-8
This article is cited by
-
Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm
Journal of Perinatology (2024)
-
Plasma serotonergic biomarkers are associated with hypoxemia events in preterm neonates
Pediatric Research (2023)
-
Chorioamnionitis-exposure alters serum cytokine trends in premature neonates
Journal of Perinatology (2023)
-
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Molecular and Cellular Pediatrics (2021)
-
Hyperoxia-activated circulating extracellular vesicles induce lung and brain injury in neonatal rats
Scientific Reports (2021)